Ethical implications of genetic testing of susceptibility to breast cancer

Abstract Breast cancer is a public health problem because it the malignant neoplasm with highest incidence in women worldwide. The hereditary form corresponds to about 5% 10% of all cases and directly related inheritance genetic mutations. main ones occur BRCA1 BRCA2 tumor suppressor genes. identification these mutations extremely important high risk breast development this population, allowing differentiated screening strategies adoption reduction measures. However, reflections on ethical aspects indiscriminate use testing are necessary. objective study was evaluate knowledge opinion physicians an oncology reference center indication tests for susceptibility given dilemmas which they submitted medical practice.